These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 19715526

  • 1. Tamoxifen therapy in kidney-transplant patients presenting with severe encapsulating peritoneal sclerosis after treatment for acute humoral rejection.
    Mohamed AO, Kamar N, Nogier MB, Esposito L, Duffas JP, Rostaing L.
    Exp Clin Transplant; 2009 Sep; 7(3):164-7. PubMed ID: 19715526
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation.
    Moustafellos P, Hadjianastassiou V, Roy D, Velzeboer NE, Maniakyn N, Vaidya A, Friend PJ.
    Transplant Proc; 2006 Nov; 38(9):2913-4. PubMed ID: 17112862
    [Abstract] [Full Text] [Related]

  • 4. Posttransplant encapsulating peritoneal sclerosis: presentation of cases and review of the literature.
    Dębska-Ślizien A, Konopa J, Januszko-Giergielewicz B, Wołyniec Z, Wołyniec W, Chamienia A, Rutkowski B.
    J Nephrol; 2013 Nov; 26(5):906-11. PubMed ID: 23065918
    [Abstract] [Full Text] [Related]

  • 5. A role for everolimus in post-transplant encapsulating peritoneal sclerosis: first case report.
    Sud R, Garry L, Spicer ST, Allen RD, Eris JM, Wyburn K, Verran D, Cooper CL, Chadban S.
    Nephrology (Carlton); 2014 Apr; 19 Suppl 1():27-30. PubMed ID: 24460661
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. mTOR inhibitors for management of encapsulating peritoneal sclerosis: a review of literatures.
    Ghadimi M, Dashti-Khavidaki S, Khalili H.
    Ren Fail; 2016 Nov; 38(10):1574-1580. PubMed ID: 27425661
    [Abstract] [Full Text] [Related]

  • 9. Development of encapsulating peritoneal sclerosis following bacterial peritonitis in a peritoneal dialysis patient.
    Hsu YH, Hsia CC, Tsai DM, Tu HY, Hung KY, Huang JW.
    Am J Kidney Dis; 2010 Jan; 55(1):198-202. PubMed ID: 19782452
    [No Abstract] [Full Text] [Related]

  • 10. Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: a single-center experience in Japan.
    Yamamoto H, Nakayama M, yamamoto R, Otsuka Y, Takahashi H, Kato N, Hayakawa H, Hasegawa T, Ikeda M, Yokoyama K, Kawaguchi Y, Mukai H, Hosoya T.
    Adv Perit Dial; 2002 Jan; 18():135-8. PubMed ID: 12402605
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis in Slovenia.
    Lindic J, Rupnik AT, Tomazic J, Skoberne A, Gucek A, Ferluga D, Pintar T, Ales A, Kovac D, Kveder R, Pajek J, Savicki-Ponikvar B, Bren A.
    Ther Apher Dial; 2009 Aug; 13(4):282-7. PubMed ID: 19695060
    [Abstract] [Full Text] [Related]

  • 14. Encapsulating peritoneal sclerosis: experience of a tertiary referral center.
    Phelan PJ, Walshe JJ, Al-Aradi A, Garvey JP, Finnegan K, O'Kelly P, McWilliams J, Ti JP, Morrin MM, Morgan N, Conlon PJ.
    Ren Fail; 2010 May; 32(4):459-63. PubMed ID: 20446784
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Peritoneal dialysis: a time-limited therapy because of encapsulating peritoneal sclerosis? No, but better approaches are available].
    Garosi G.
    G Ital Nefrol; 2010 May; 27(5):456-63. PubMed ID: 20922676
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.